76 results found | searching for "veterinary"
-
-
Understanding the $549 Million Base Editing Market: A Deep Dive https://www.marketsandmarkets.com/Market-Reports/base-editing-market-21238371.html The base editing market is projected to reach USD 549 million by 2028 from an estimated USD 270 million in 2023, at a CAGR of 15.2% during the forecast period. Factors like the rising prevalence of genetic diseases, coupled with advancements in molecular biology and biotechnology, has spurred research and development efforts in base editing technologies. Additionally, the growing investment in gene therapy and the biopharmaceutical sector further accelerates the expansion of the base editing market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21238371 Based on product & service, the base editing market is segmented into products and services. The product segment is further categorized as platform, kits & reagents, plasmids, and base editing libraries. The service segment is further categorized as gRNA design/synthesis, cell line engineering, and other services. Platform accounted for the largest share of the global base editing market in 2022. The large share of this segment can primarily be attributed to the increasing demand for base editing in molecular studies and the discovery of new therapies. Based on type, the global base editing market is segmented into DNA base editing, and RNA base editing. In 2022, DNA-targeted base editing accounted for the largest share of the base editing market. The large share of this segment can be attributed to the factor that DNA base editing leads to changes in the genomic DNA sequence, making the edits permanent. This can be advantageous when long-lasting or heritable modifications are desired, as the edited DNA is passed on to subsequent generations of cells. Based on targeted base, the base editing market has been segmented into cytosine base editing, and adenine base editing. In 2022, cytosine base editing accounted for the largest market share because cytosine base editors (CBEs) are designed to convert a C-G base pair to a T-A base pair. This type of transition is more common in naturally occurring DNA sequences, making cytosine editing suitable for introducing changes that are biologically relevant. Based on application, the base editing market has been segmented into drug discovery & development, agriculture, and veterinary. In 2022, the drug discovery & development segment accounted for the largest share of the base editing market. The large share of this segment can be attributed to the potential of base editing for developing novel therapeutic interventions by correcting disease-causing mutations at the DNA or RNA level. This is especially relevant for genetic disorders where a single nucleotide mutation is responsible for the disease. Based on end users, the base editing market has been segmented into pharmaceutical & biotechnology companies, academic research institutes, and contract research organizations. In 2022, the pharmaceutical & biotechnology segment accounted for the largest share of the base editing market. The large share of this segment is due to the potential of base editing in drug development; companies in the pharmaceutical and biotechnology sectors are investing in this technology to secure intellectual property, technology, and product rights and gain a competitive advantage in the rapidly evolving field of genome editing. For instance, in October 2023, Beam Therapeutics announced an agreement with Eli Lilly and Company (Lilly) to acquire certain rights under Beam’s collaboration and license agreement with Verve Therapeutics, Inc., including Beam’s opt-in rights to co-develop and co-commercialize Verve’s base editing programs for cardiovascular disease. The key regional markets for the global base editing market are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the market. The large share of this region is due to the robust biotechnology and pharmaceutical industry, with numerous companies dedicated to drug discovery, development, and therapeutic applications. These companies actively invest in and adopt emerging technologies like base editing for advancing their research and product pipelines. However, most of the growth in the market is expected from emerging countries across Asia Pacific. During the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the emergence of CROs for outsourcing drug discovery-related research projects and increasing pharmaceutical drug pipelines are driving growth in these markets. Key players in the global Base editing market include Danaher Corporation (US), Merck KGaA (Germany), Revvity (US), Maravai LifeSciences (US), GenScript (China), Beam Therapeutics (US), Intellia Therapeutics, Inc. (US), Cellectis (France), ElevateBio (US), Creative Biogene (US), Bio Palette Co., Ltd (Japan), Addgene (US), Synthego (US), EdiGene, Inc. (China), Shape TX (US), Pairwise (US), ProQR Therapeutics (Netherlands), QI-Biodesign (China), KromaTiD, Inc. (US), and GenKOre. (South Korea). Recent Developments of Base Editing Industry: In May 2023, Revvity entered into a license agreement with AstraZeneca for the technology underlying its Pin-point base editing system, a next-generation modular gene editing platform with a strong safety profile to support their creation of cell therapies for the treatment of cancer and immune-mediated diseases. In July 2022, Beam Therapeutics entered a collaboration with Verve Therapeutics. Beam Tx granted Verve Tx a license toward an additional liver-mediated cardiovascular disease target. In February 2022, Intellia Therapeutics acquired Rewrite Therapeutics; a private biotechnology company focused on advancing novel DNA writing technologies. This acquisition has expanded Intellia’s industry-leading genome editing toolbox by adding a platform that is highly complementary to its existing CRISPR/Cas9 and base editing technologies. -
-
Animal Disinfectants Market in 2024: In 2024, the global animal disinfectants market is experiencing robust growth, propelled by a combination of factors that underscore its critical role in ensuring the health and welfare of animals worldwide. From agriculture to veterinary care, the demand for effective disinfectant solutions continues to rise, driven by evolving regulatory landscapes and heightened awareness of biosecurity measures. Fore more info :- https://onetable.world/read-blog/59496
-
-
Animal Disinfectants Market Growth in 2024: In 2024, the global animal disinfectants market is experiencing robust growth, propelled by a combination of factors that underscore its critical role in ensuring the health and welfare of animals worldwide. From agriculture to veterinary care, the demand for effective disinfectant solutions continues to rise, driven by evolving regulatory landscapes and heightened awareness of biosecurity measures. Fore more info :- https://paidforarticles.com/what-is-animal-disinfectants-market-2024-ensuring-health-and-safety-796580
-
-
Bio Decontamination Market Anticipated to Reach $339 Million by 2028 https://www.marketsandmarkets.com/Market-Reports/bio-decontamination-market-104696777.html The global Bio Decontamination market is projected to reach USD 339 million by 2028 from USD 238 million in 2023, at a CAGR of 7.3% during the forecast period. The growth of this market is majorly driven by Increased outsourcing of bio decontamination services and Rising growth in pharmaceutical & biotechnology industries. However, the Rising adoption of single-use medical devices may restrain the growth of this market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Based on Product & Service, the Bio Decontamination Market is segmented into Consumables, Equipment, & Services. The Services segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are: The services segment is growing mainly due to its low cost (as compared to the costs incurred while setting up in-house decontamination facilities, buying equipment, allotting storage space, and in repair & maintenance). Based on the Agent type, the Bio Decontamination Market is segmented into Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, Nitrogen Dioxide, The Hydrogen Peroxide segment is expected to dominate the market during the forecast period due Vaporized hydrogen peroxide is one of the commonly used bio decontamination agents moreover it has wide application areas, including pharmaceutical & medical device manufacturing, biosciences & biotechnology research labs, hospitals & healthcare facilities, and veterinary applications. Several regulations also support the use of hydrogen peroxide, such as the US EPA. Based on the Type, the Bio Decontamination Market is segmented into Chamber Decontamination, Room Decontamination. The Chamber Decontamination segment is expected to dominate the market during the forecast period because the power consumption of bio decontamination chambers is less than room decontamination. It is also less costly, which has stimulated the adoption of chamber bio decontamination. Based on the end user, the Bio Decontamination Market is segmented into Pharmaceutical & Medical Device Manufacturing Companies, Life Sciences & Biotechnology Research Organizations, Hospitals & Healthcare Facilities. The Pharmaceutical & Medical Device Manufacturing Companies is expected to dominate the market during the forecast period due to Bio decontamination is an integral part of the pharmaceutical manufacturing process. Pharmaceutical manufacturing companies are facing increased pressure to ensure the integrity of their products and maintain manufacturing facilities that are free from contamination of any kind. Failure to maintain good manufacturing practices (GMP) has resulted in severe consequences. Similarly, medical device manufacturing companies also must follow strict guidelines to prevent and control medical devices from being contaminated at their facilities. Based on the region, the Bio Decontamination Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2022, North America accounted for the largest share of the Bio Decontamination Market. Growth in the North American market is mainly driven by the growing demand for bio decontamination technologies from the healthcare industry to minimize the occurrence of hospital-acquired infections (HAIs) and the increasing presence of major manufacturers in the region. The significant players in the Bio Decontamination market are Steris PLC (US), Ecolab (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang TAILIN Bioengineering Co., LTD (China), Howorth Air Technology Ltd. (UK), Solidfog Technologies (Belgium), ClorDiSys (US), Amira (Italy) Recent Developments In July 22, Ecolab’s (US) Bioquell HPV-AQ received an authorized approval for use in all territories of the European Union and the European Economic Area. In Dec 2022, the TOMI Environmental Solutions, Inc (US) launched new SteraMist products, which include the Select Plus-a hybrid product consisting of the Company’s current Surface Select and Environment systems. (The system is 24 volts, allowing for universal outlet usage and convert more of the hydrogen peroxide BIT Solution to hydroxyl radicals thus lowering H2O2 PPM levels allowing for faster turnaround time). -
-
Market Surge: PCR Technologies Expected to Hit $18.3 Billion by 2027 https://www.marketsandmarkets.com/Market-Reports/pcr-technologies-market-96291811.html MarketsandMarkets expect the Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. Factors like Increasing emphasis on disease prevention and control, growing animal population and pet ownership, rising demand for veterinary medicines, and growing awareness of animal welfare are expected to drive the development and growth of the veterinary API market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91801752 Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028 In this report, the Veterinary API market is segmented on the basis of API Type, Synthesis Type, Route of Administration, Animal Type, and region. Based on API Type, market segments are divided into six types such as Parasiticides, Vaccines, Antimicrobials, Anti-inflammatory, Hormones, and Other Veterinary APIs. The Parasiticides segment accounted for the largest share of the global Veterinary API market in 2022. The rising R&D investment on veterinary API manufacturing, rising parasitic infection in companion and livestock animals are additional factors that are expected to boost market expansion throughout the projected period. Based on Synthesis type, Veterinary API market is segmented into three types such as Chemical based API, Biological API, and Highly potent API. The Chemical based API segment accounted for the largest share of the global Veterinary API market in 2022. Wide Range of Therapeutic Options for chemical based API manufacturing, Good stability and longer shelf life compared to some biological APIs are some of the factors that are expected to boost the segment in this market. Based on Route of Administration, Veterinary API market is segmented into four types such as Oral, Injectable, Topical, and Others. The Oral segment accounted for the largest share of the global Veterinary API market in 2022. Wide applicability in various animal species, easy to administer all the medications, and flexibility in dosing are some of the factors to grow the segment in this market. Based on Animal Type, Veterinary API market is segmented into four types such as companion and livestock animals. The companion animals segment accounted for the largest share of the global Veterinary API market in 2022. Increasing product portfolio by pharmaceutical companies for companion animals healthcare and advances in veterinary medicines are the factors to grow the segment in this market. The Veterinary API Market is categorized into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In terms of market share, North America was the dominant region for Veterinary APIs globally in 2022. It is anticipated that a major drivers impacting the North America market growth would be development of advanced drug delivery systems, novel formulations, and innovative diagnostic tools, well-established regulatory standards for veterinary pharmaceuticals, and advanced veterinary healthcare infrastructure. The prominent players in the global Veterinary API Market are Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insulnsud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China) Recent Developments of Veterinary API Industry In 2021, Sequent Scientific Ltd. (India) received WHO–GENEVA approval for API Praziquantel (Anthelmintic) under the prequalification program. In 2020, Sequent Scientific Ltd. Opened a state-of-the-art animal health R&D center in Mumbai, India. -
-
Market Surge: Veterinary API Expected to Hit $11.9 Billion by 2028 https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.html MarketsandMarkets expect the Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. Factors like Increasing emphasis on disease prevention and control, growing animal population and pet ownership, rising demand for veterinary medicines, and growing awareness of animal welfare are expected to drive the development and growth of the veterinary API market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91801752 Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028 In this report, the Veterinary API market is segmented on the basis of API Type, Synthesis Type, Route of Administration, Animal Type, and region. Based on API Type, market segments are divided into six types such as Parasiticides, Vaccines, Antimicrobials, Anti-inflammatory, Hormones, and Other Veterinary APIs. The Parasiticides segment accounted for the largest share of the global Veterinary API market in 2022. The rising R&D investment on veterinary API manufacturing, rising parasitic infection in companion and livestock animals are additional factors that are expected to boost market expansion throughout the projected period. Based on Synthesis type, Veterinary API market is segmented into three types such as Chemical based API, Biological API, and Highly potent API. The Chemical based API segment accounted for the largest share of the global Veterinary API market in 2022. Wide Range of Therapeutic Options for chemical based API manufacturing, Good stability and longer shelf life compared to some biological APIs are some of the factors that are expected to boost the segment in this market. Based on Route of Administration, Veterinary API market is segmented into four types such as Oral, Injectable, Topical, and Others. The Oral segment accounted for the largest share of the global Veterinary API market in 2022. Wide applicability in various animal species, easy to administer all the medications, and flexibility in dosing are some of the factors to grow the segment in this market. Based on Animal Type, Veterinary API market is segmented into four types such as companion and livestock animals. The companion animals segment accounted for the largest share of the global Veterinary API market in 2022. Increasing product portfolio by pharmaceutical companies for companion animals healthcare and advances in veterinary medicines are the factors to grow the segment in this market. The Veterinary API Market is categorized into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In terms of market share, North America was the dominant region for Veterinary APIs globally in 2022. It is anticipated that a major drivers impacting the North America market growth would be development of advanced drug delivery systems, novel formulations, and innovative diagnostic tools, well-established regulatory standards for veterinary pharmaceuticals, and advanced veterinary healthcare infrastructure. The prominent players in the global Veterinary API Market are Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insulnsud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China) Recent Developments of Veterinary API Industry In 2021, Sequent Scientific Ltd. (India) received WHO–GENEVA approval for API Praziquantel (Anthelmintic) under the prequalification program. In 2020, Sequent Scientific Ltd. Opened a state-of-the-art animal health R&D center in Mumbai, India. -
-
Veterinary Third Party Manufacturing Company in India https://www.alicantobiotech.in/veterinary-third-party-manufacturing-company-in-india/ Alicanto Biotech is best veterinary third party manufacturing company in india. We offer a quality-assured and top-class veterinary product range like feed suplements liquid, veterinary bolus, veterinary liquid injections, veterinary liquid, veterinary dry injections, veterinary powders, veterinary spray/soap etc. If you want more information about veterinary third party manufacturing call us now: 7888491021.
-
-
https://refitanimalcare.com/blog/poultry-salmonellosis-causes-symptoms-treatment-and-prevention/ #poultrysalmonellosis #refit #refitanimalcare #poultryfeedsupplement #veterinary -
-
Finding Your Perfect Companion: Munchkin Kittens for Homes In the world of feline companionship, Munchkin kittens have captured the hearts of many with their adorable appearance and playful personalities. If you're considering adding a furry friend to your family, Munchkin kittens might just be the perfect choice. In this article, we'll explore what makes Munchkin kittens so special and why they are ideal for homes. What are Munchkin Kittens? Munchkin kittens are known for their distinctively short legs, which result from a genetic mutation. Despite their diminutive stature, these kittens possess boundless energy and a curious nature. Their playful antics and affectionate demeanor make them delightful companions for individuals and families alike. Why Choose a Munchkin Kitten for Your Home? Adorable Appearance: One glance at a Munchkin kitten is all it takes to fall in love. Their short legs and sweet faces are irresistibly charming, making them the center of attention wherever they go. Compact Size: Munchkin kittens may have short legs, but their hearts are overflowing with love. Their petite size makes them well-suited for apartment living or households with limited space. Playful Personality: Despite their small stature, Munchkin kittens are full of energy and love to play. They'll keep you entertained for hours with their acrobatic feats and mischievous antics. Affectionate Nature: Munchkin kittens are known for their affectionate nature and love to cuddle up with their human companions. They form strong bonds with their owners and thrive on attention and affection. Easy to Care For: Munchkin kittens are relatively low-maintenance compared to some other breeds. With regular grooming and veterinary care, they can live long, healthy lives as cherished members of your family. Finding Munchkin Kittens for Homes If you're ready to welcome a Munchkin kitten into your home, it's essential to find a reputable breeder or adoption agency. Websites like Munchkinkittens4homes specialize in connecting prospective owners with Munchkin kittens in need of loving homes. Before bringing a kitten into your family, be sure to research breeders, ask plenty of questions, and ensure that the kitten has received proper care and socialization. Final Thoughts Munchkin kittens bring joy, love, and laughter into any home lucky enough to have them. With their adorable appearance, playful personality, and affectionate nature, these kittens are the perfect companions for individuals and families alike. If you're considering adding a furry friend to your household, consider opening your heart and home to a Munchkin kitten from Munchkinkittens4homes. https://www.munchkinkittens4homes.com/shop-munchkin-cats-for-sale/ -
-
Refit Animal Care Wishing You Happy World Veterinary Day #refitanimalcare #refit #WorldVeterinaryDay #veterinaryday
Copyright 2019 © P-tweets Refunds